2nd Jul 2012 08:30
- Chinese, Japanese data comes in better than expected - RBS falls on Libor issues - Barclays Chairman resigns London's blue chips edged higher on Monday morning after manufacturing data in China and Japan boosted sentiment. China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last mont
Read more2nd Jul 2012 07:30
City sources predict the FTSE 100 will open up six points from Friday's close of 5,571, tracking Asian stocks higher following a round of positive data in both China and Japan. Also boosting sentiment is the progress made at the EU summit held at the end of last week, at which a number of significan
Read more2nd Jul 2012 07:22
Pharmaceuticals giant GlaxoSmithKline (GSK) has revealed positive results from four pivotal phase III studies for its once-daily chronic obstructive pulmonary disease (COPD) treatment, LAMA/LABA (UMEC/VI. GSK and Theravance studied some 4,000 patients with COPD through two 24-week efficacy studies
Read more29th Jun 2012 13:10
GlaxoSmithKline has extended its offer to acquire all of the outstanding shares of Human Genome Sciences for 1,300 cents per share until 17:00 on July 20th. GSK's tender offer will expire after 16 July, the deadline set by HGS for submission of definitive acquisition proposals, after which GSK wil
Read more21st Jun 2012 08:40
- Chinese PMI falls to seven-month low - Fed extends 'the twist', lowers GDP forecast - Miners provide a drag in London Disappointing economic data from China and a downward revision to US growth dented the Footsie in early trading on Thursday, with mining stocks bearing the brunt of the sell-off.
Read more12th Jun 2012 08:40
- Markets still digesting Spanish request for aid - Investors look ahead to Greek elections, Italian bond auction - Miners and banks drop early on London's blue-chip index opened flat on Tuesday morning with all eyes on the Eurozone following the recent Spanish request for aid and ahead of the cruc
Read more12th Jun 2012 07:30
City sources predict the FTSE 100 will open down 8 points from yesterday's close of 5,432 as investors take stock after the Eurozone's decision to lend troubled economy Spain up to 100bn euros. The bailout deal has failed to pacify worried investors in the US and Asia, where stocks fell overnight as
Read more12th Jun 2012 07:09
Pharmaceuticals giant GlaxoSmithKline has signed an agreement to buy eczema treatment drug 'Toctino' from Basilea Pharmaceutica. Toctino, otherwise known as 'alitretinoin', is a prescription-only, once-daily, oral retinoid used for severe chronic adult hand eczema which is unresponsive to other pot
Read more11th Jun 2012 09:37
Antofagasta: RBS Capital Markets downgrades to underperform. Ashtead: Jefferies keeps buy recommendation and 300p target. Barclays: Bank of America Merrill Lynch keeps buy rating and 370p target; Oriel Securities reiterates buy recommendation and 285p target. BP: Nomura retains neutral stance and
Read more8th Jun 2012 16:37
- Spanish bailout could be on the cards - Fitch downgrades Spain to BBB - Investors look ahead of Chinese data this weekend Rumours about an imminent recapitalisation of Spain's banking sector and concerns over global growth were doing the rounds on Friday, yet the Footsie still managed to pare los
Read more8th Jun 2012 14:55
Metals prices were retreating throughout Friday's session, pressuring mining stock lower. Vedanta, Kazakhmys, Antofagasta, Xstrata, Rio Tinto, Glencore and ENRC were among the worst performers. A stronger dollar was making greenback-denominated commodities more expensive early on, with crude prices
Read more8th Jun 2012 14:51
Pharmaceuticals leviathan GlaxoSmithkline has extended the offer period for its hostile take-over of US sector peer Human Genome Sciences (HGS). The offer period had been set to run out at the end of June 7th, but has now been extended to 17:00 (New York City time) on Friday, June 29th. Glaxo laun
Read more25th May 2012 06:53
David Cameron will face demands from Tory MPs to redraw Britain's relationship with Europe in the event of a Greek exit from the Eurozone, senior government sources believe. No 10 and the Foreign and Commonwealth Office say that treaties governing the European Union will have to be rewritten after t
Read more15th May 2012 13:13
Drugs giant GlaxoSmithKline is to take full control of Cellzome, a company specialising in the study of protein structures and functions. Glaxo, which currently owns just under one fifth of Cambridge-based Cellzome, is paying £61m in cash to buy up the rest of the company, which will become part of
Read more9th May 2012 11:36
- Weir and Sage fall heavily - ITV, Sainsbury, Glencore higher after updates - Footsie hits new YTD lows on euro concerns London's blue chip index had sunk to levels not seen since late December by Wednesday lunchtime, as political uncertainty in the Eurozone continues to cloud the outlook for the
Read more